Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation? | Zendy

Mehmet Birhan Yılmaz | Zendy; Osman Can Yontar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation?

Author(s) -

Mehmet Birhan Yılmaz,

Osman Can Yontar

Publication year - 2008

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehn460

Subject(s) - medicine , heart failure , asymmetric dimethylarginine , cardiology , intensive care medicine , biochemistry , chemistry , amino acid , arginine

We are grateful to Dr Yilmaz et al. 1 for their interest in our article on smoking and clinical outcomes in patients with heart failure. They raise several important issues, including an alternative explanation for the findings from OPTIMIZE-HF that smokers hospitalized with heart failure had lower risk adjusted in-hospital mortality, shorter length of stay, and similar early post discharge mortality compared with …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research